BBO
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT • NASDAQ • Stock Fundamentals
BridgeBio Oncology Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Eli Wallace, with a market cap of $684.9M.
Market Cap$684.9M
CEOEli Wallace
CountryUnited States of America
Next EarningsAug 11, 2026 · in 2 monthsQ3 2026
Financials
BBO
BridgeBio Oncology Therapeutics, Inc. Common Stock FAQ
Common questions about BridgeBio Oncology Therapeutics, Inc. Common Stock
BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) has a market capitalization of $684.9M and trades on NASDAQ.